Noor Alqudah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noor Alqudah has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Hisham M. Jammal
Department of Ophthalmology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
5 shared publications - Yousef Khader
Jordan University of Science and Technology, Irbid, Jordan
4 shared publications - Asem A. Alqudah
Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan
3 shared publications Sarah Alshamarti
Department of Ophthalmology, Alqadisiyah University, Faculty of Medicine, Diwaniyeh, Iraq
3 shared publications- Wedad Al-Dolat
Department of Ophthalmology, Faculty of Medicine, Yarmouk University, Irbid, Jordan
3 shared publications - Abdelwahab Aleshawi
Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan
2 shared publications
Latest Publications
- Open Access
- 13 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4599
Real-World Outcomes of Switching to Aflibercept 8 mg in Previously Treated Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Background: Neovascular age-related macular degeneration (nAMD) remains a leading cause of irreversible central vision loss. Although anti-vascular endothelial growth factor (anti-VEGF) therapy has transformed management, pivotal trials enrolled exclusively treatment-naïve patients, leaving clinicians without pooled evidence to guide switching decisions in previously treated eyes. This systematic review and meta-analysis assessed real-world visual, anatomical, durability, and safety outcomes following switching to aflibercept 8 mg in previously treated nAMD. Methods: Following PRISMA 2020 guidelines, we searched PubMed, Embase, Web of Science, CENTRAL, Scopus, and Google Scholar through April 2026. Studies reporting switching to aflibercept 8 mg with change in best-corrected visual acuity (BCVA), central subfield thickness (CST), or treatment interval were included. Continuous outcomes were pooled using random-effects models with Hartung–Knapp–Sidik–Jonkman adjustment; proportions were estimated using generalized linear mixed models. Methodological quality was evaluated using the JBI Critical Appraisal Checklist for Case Series. Certainty of evidence was assessed using GRADE. The protocol was registered with PROSPERO (CRD420261371334). Results: Twenty-one studies met inclusion criteria. BCVA remained stable (WMD: −0.017 logMAR; 95% CI: −0.027 to −0.007; +0.83 ETDRS letters; I2 = 0%). CST decreased significantly (WMD: −21.5 µm; 95% CI: −29.3 to −13.7; I2 = 56.0%), and treatment intervals extended by +1.79 weeks (95% CI: +1.32 to +2.27; I2 = 74.3%). Intraretinal and subretinal fluid each resolved in 37.5% of eyes. Intraocular inflammation was rare across 9959 treated eyes, though this pool was not restricted to switched eyes, with no confirmed retinal vasculitis. Sensitivity analyses confirmed robustness across all co-primary estimates. GRADE certainty was low for BCVA and very low for CST and treatment interval. Conclusions: Low-certainty evidence suggests that switching to aflibercept 8 mg preserves visual acuity, while very-low-certainty evidence suggests reductions in central subfield thickness and modest extension of treatment intervals. Intraocular inflammation was rare, though safety denominators included non-switch eyes. These findings provide preliminary pooled estimates to inform switch decisions in previously treated eyes.
- 13 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4599
Open AccessReal-World Outcomes of Switching to Aflibercept 8 mg in Previously Treated Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Background: Neovascular age-related macular degeneration (nAMD) remains a leading cause of irreversible central vision loss. Although anti-vascular endothelial growth factor (anti-VEGF) therapy has transformed management, pivotal trials enrolled exclusively treatment-naïve patients, leaving clinicians without pooled evidence to guide switching decisions in previously treated eyes. This systematic review and meta-analysis assessed real-world visual, anatomical, durability, and safety outcomes following switching to aflibercept 8 mg in previously treated nAMD. Methods: Following PRISMA 2020 guidelines, we searched PubMed, Embase, Web of Science, CENTRAL, Scopus, and Google Scholar through April 2026. Studies reporting switching to aflibercept 8 mg with change in best-corrected visual acuity (BCVA), central subfield thickness (CST), or treatment interval were included. Continuous outcomes were pooled using random-effects models with Hartung–Knapp–Sidik–Jonkman adjustment; proportions were estimated using generalized linear mixed models. Methodological quality was evaluated using the JBI Critical Appraisal Checklist for Case Series. Certainty of evidence was assessed using GRADE. The protocol was registered with PROSPERO (CRD420261371334). Results: Twenty-one studies met inclusion criteria. BCVA remained stable (WMD: −0.017 logMAR; 95% CI: −0.027 to −0.007; +0.83 ETDRS letters; I2 = 0%). CST decreased significantly (WMD: −21.5 µm; 95% CI: −29.3 to −13.7; I2 = 56.0%), and treatment intervals extended by +1.79 weeks (95% CI: +1.32 to +2.27; I2 = 74.3%). Intraretinal and subretinal fluid each resolved in 37.5% of eyes. Intraocular inflammation was rare across 9959 treated eyes, though this pool was not restricted to switched eyes, with no confirmed retinal vasculitis. Sensitivity analyses confirmed robustness across all co-primary estimates. GRADE certainty was low for BCVA and very low for CST and treatment interval. Conclusions: Low-certainty evidence suggests that switching to aflibercept 8 mg preserves visual acuity, while very-low-certainty evidence suggests reductions in central subfield thickness and modest extension of treatment intervals. Intraocular inflammation was rare, though safety denominators included non-switch eyes. These findings provide preliminary pooled estimates to inform switch decisions in previously treated eyes.
- Open Access
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331670
Association between hair cortisol levels and keratoconus: A prospective study
Introduction: Keratoconus is a progressive corneal disorder characterized by corneal thinning often leading to significant visual impairment. Recent research suggests a potential role of cortisol in the development and progression of keratoconus. However, the relationship between cortisol levels and keratoconus severity remains poorly understood. Purpose: To investigate the association between hair cortisol levels and keratoconus severity in a Jordanian population, exploring whether cortisol could serve as a potential biomarker for disease progression or stability. Methods: We conducted a prospective, observational study at King Abdullah University Hospital in Jordan. Sixty participants aged 18–30 years were categorized into three groups: Healthy (n = 20), Progressive Keratoconus (n = 20), and Stable Keratoconus (n = 20). Demographic, clinical, and ocular data were collected, including age, gender, hair cortisol levels, and corneal topography indices (Kmax, Kmean, and thinnest corneal location). Results: The median cortisol level was significantly higher in the Progressive Keratoconus group (987 pg/mL) compared to the Stable group (300 pg/mL, p-value <0.001). Regression analysis revealed a significant negative association between cortisol levels and stable keratoconus (β = −1.31, p < 0.001). No significant association was observed for progressive keratoconus after adjustment for age and gender. Correlation analysis showed no significant associations between cortisol levels and BMI, Kmax, or Kmean. Cortisol levels also did not vary significantly across keratoconus severity categories in either eye. Conclusion: Elevated cortisol levels may be associated with keratoconus progression, while lower levels appear linked to disease stability. Cortisol could serve as a potential biomarker for disease monitoring; however, further multicenter studies are needed to validate these findings and clarify cortisol’s role in keratoconus pathogenesis.
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331670
Open AccessAssociation between hair cortisol levels and keratoconus: A prospective study
Introduction: Keratoconus is a progressive corneal disorder characterized by corneal thinning often leading to significant visual impairment. Recent research suggests a potential role of cortisol in the development and progression of keratoconus. However, the relationship between cortisol levels and keratoconus severity remains poorly understood. Purpose: To investigate the association between hair cortisol levels and keratoconus severity in a Jordanian population, exploring whether cortisol could serve as a potential biomarker for disease progression or stability. Methods: We conducted a prospective, observational study at King Abdullah University Hospital in Jordan. Sixty participants aged 18–30 years were categorized into three groups: Healthy (n = 20), Progressive Keratoconus (n = 20), and Stable Keratoconus (n = 20). Demographic, clinical, and ocular data were collected, including age, gender, hair cortisol levels, and corneal topography indices (Kmax, Kmean, and thinnest corneal location). Results: The median cortisol level was significantly higher in the Progressive Keratoconus group (987 pg/mL) compared to the Stable group (300 pg/mL, p-value <0.001). Regression analysis revealed a significant negative association between cortisol levels and stable keratoconus (β = −1.31, p < 0.001). No significant association was observed for progressive keratoconus after adjustment for age and gender. Correlation analysis showed no significant associations between cortisol levels and BMI, Kmax, or Kmean. Cortisol levels also did not vary significantly across keratoconus severity categories in either eye. Conclusion: Elevated cortisol levels may be associated with keratoconus progression, while lower levels appear linked to disease stability. Cortisol could serve as a potential biomarker for disease monitoring; however, further multicenter studies are needed to validate these findings and clarify cortisol’s role in keratoconus pathogenesis.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Clinical Optometry
- Vol. ume 17, 243-247
Contact Lens-Associated Serratia marcescens Keratitis: A Case Report
Serratia marcescens (S. marcescens) keratitis is a rare, sight-threatening infection primarily seen in contact lens users. A 22-year-old female developed sudden ocular symptoms two days after contact lens use. Examination revealed significant conjunctival injection, anterior chamber inflammation, and a corneal abscess with an epithelial defect. Despite initial moxifloxacin treatment, her condition worsened, requiring a switch to fortified vancomycin, ceftriaxone, and voriconazole. Cultures confirmed S. marcescens, allowing treatment to be streamlined to fortified ceftriaxone. The infection gradually resolved, with visual acuity returning to 20/20 and minimal residual scarring noted at one month.
- 1 August 2025
- Published by Taylor & Francis in Clinical Optometry
- Vol. ume 17, 243-247
Open AccessContact Lens-Associated Serratia marcescens Keratitis: A Case Report
Serratia marcescens (S. marcescens) keratitis is a rare, sight-threatening infection primarily seen in contact lens users. A 22-year-old female developed sudden ocular symptoms two days after contact lens use. Examination revealed significant conjunctival injection, anterior chamber inflammation, and a corneal abscess with an epithelial defect. Despite initial moxifloxacin treatment, her condition worsened, requiring a switch to fortified vancomycin, ceftriaxone, and voriconazole. Cultures confirmed S. marcescens, allowing treatment to be streamlined to fortified ceftriaxone. The infection gradually resolved, with visual acuity returning to 20/20 and minimal residual scarring noted at one month.
- Open Access
- 4 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3179
Assessment of Serum Cytokine Levels in Keratoconus Patients
Background: While keratoconus (KC) has traditionally been classified as a non-inflammatory corneal disorder, emerging evidence suggests that inflammatory processes may be involved in its pathogenesis. This study investigated whether systemic inflammation contributes to KC development by measuring serum levels of key pro-inflammatory cytokines in KC patients compared to healthy controls. Methods: This cross-sectional comparative study included 60 participants aged 18–30 and was divided into three equal groups: healthy controls, progressive KC, and stable KC. The levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) in the serum were measured through an enzyme-linked immunosorbent assay. KC severity was classified based on mean keratometry values. Results: There were no significant differences detected in serum IL-6, TNF-α, and IL-1β levels across groups (p > 0.05). Moreover, no significant correlations were found between systemic cytokine levels and KC severity categories (p > 0.05). Conclusions: Systemic levels of IL-1β, IL-6, and TNF-α do not significantly differ between KC patients and controls nor do they correlate with disease severity, reinforcing the hypothesis that KC involves primarily local inflammatory processes.
- 4 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3179
Open AccessAssessment of Serum Cytokine Levels in Keratoconus Patients
Background: While keratoconus (KC) has traditionally been classified as a non-inflammatory corneal disorder, emerging evidence suggests that inflammatory processes may be involved in its pathogenesis. This study investigated whether systemic inflammation contributes to KC development by measuring serum levels of key pro-inflammatory cytokines in KC patients compared to healthy controls. Methods: This cross-sectional comparative study included 60 participants aged 18–30 and was divided into three equal groups: healthy controls, progressive KC, and stable KC. The levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) in the serum were measured through an enzyme-linked immunosorbent assay. KC severity was classified based on mean keratometry values. Results: There were no significant differences detected in serum IL-6, TNF-α, and IL-1β levels across groups (p > 0.05). Moreover, no significant correlations were found between systemic cytokine levels and KC severity categories (p > 0.05). Conclusions: Systemic levels of IL-1β, IL-6, and TNF-α do not significantly differ between KC patients and controls nor do they correlate with disease severity, reinforcing the hypothesis that KC involves primarily local inflammatory processes.
- Open Access
- 17 April 2025
- Published by Wolters Kluwer Health in Indian Journal Of Ophthalmology
- Vol. 73 (7) , 953-958
Evaluating the efficacy and safety of iontophoresis-assisted corneal cross-linking compared to standard CXL in the treatment of keratoconus
Purpose: To compare the outcomes of standard corneal cross-linking (S-CXL) and iontophoresis-assisted CXL (I-CXL) in Jordanian keratoconus patients over a 12-month follow-up period. Design: This retrospective, observational cohort study included 107 keratoconus patients who underwent either S-CXL (n = 53) or I-CXL (n = 54) between January 2015 and December 2019. Methods: Data collected included demographic information, clinical history, and ophthalmic examinations. The primary outcome was the change in best-corrected visual acuity (BCVA) from baseline to 12 months post-procedure. Secondary outcomes included changes in spherical equivalent, cylindrical values, corneal curvature (K 1 , K 2 , K mean , K max ), and thinnest corneal location. Postoperative complications, such as corneal haze, keratitis, and the need for penetrating keratoplasty, were also assessed. Statistical analysis was performed using R statistical software. Results: The mean age of patients was 25.0 years, with a male predominance (60%). Decreased vision was the most common symptom (63%). BCVA improvement was similar in both groups at all intervals. At 12 months, the mean BCVA change was 0.05 in the S-CXL group and 0.04 in the I-CXL group. No significant differences were observed in spherical equivalent values. Corneal curvature values (K 1 , K 2 , K mean , K max ) were significantly higher in the I-CXL group. Postoperative complications were minimal, with 40% of S-CXL patients and 93% of I-CXL patients experiencing no complications. Mild haze was more common in the S-CXL group (54%). Conclusions: S-CXL demonstrated superiority in improving corneal curvature at 6 and 12 months. Postoperative complications were minimal, with higher incidence of mild haze in the S-CXL group. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these results.
- 17 April 2025
- Published by Wolters Kluwer Health in Indian Journal Of Ophthalmology
- Vol. 73 (7) , 953-958
Open AccessEvaluating the efficacy and safety of iontophoresis-assisted corneal cross-linking compared to standard CXL in the treatment of keratoconus
Purpose: To compare the outcomes of standard corneal cross-linking (S-CXL) and iontophoresis-assisted CXL (I-CXL) in Jordanian keratoconus patients over a 12-month follow-up period. Design: This retrospective, observational cohort study included 107 keratoconus patients who underwent either S-CXL (n = 53) or I-CXL (n = 54) between January 2015 and December 2019. Methods: Data collected included demographic information, clinical history, and ophthalmic examinations. The primary outcome was the change in best-corrected visual acuity (BCVA) from baseline to 12 months post-procedure. Secondary outcomes included changes in spherical equivalent, cylindrical values, corneal curvature (K 1 , K 2 , K mean , K max ), and thinnest corneal location. Postoperative complications, such as corneal haze, keratitis, and the need for penetrating keratoplasty, were also assessed. Statistical analysis was performed using R statistical software. Results: The mean age of patients was 25.0 years, with a male predominance (60%). Decreased vision was the most common symptom (63%). BCVA improvement was similar in both groups at all intervals. At 12 months, the mean BCVA change was 0.05 in the S-CXL group and 0.04 in the I-CXL group. No significant differences were observed in spherical equivalent values. Corneal curvature values (K 1 , K 2 , K mean , K max ) were significantly higher in the I-CXL group. Postoperative complications were minimal, with 40% of S-CXL patients and 93% of I-CXL patients experiencing no complications. Mild haze was more common in the S-CXL group (54%). Conclusions: S-CXL demonstrated superiority in improving corneal curvature at 6 and 12 months. Postoperative complications were minimal, with higher incidence of mild haze in the S-CXL group. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these results.
- Open Access
Differences Between Amblyopic and Fellow Eyes in Optical Coherence Tomography: A Cohort from Jordanian Population
Background and Objectives: Amblyopia is a condition where children undergo unilateral or bilateral vision loss due to a variety of disorders that impact the visual pathway. The assessment of retinal nerve fiber layer (RNFL) thickness in amblyopia has made optical coherence tomography (OCT) a useful technique for studying the pathophysiology of this condition. This study was conducted to assess OCT results for various forms of amblyopia, including macular thickness and peripapillary RNFL thickness. It is the first of its kind in Jordan. Materials and Methods: Sixty-one individuals, aged 14 to 67, who had been diagnosed with unilateral amblyopia participated in a prospective study. Both eyes underwent spectral-domain OCT imaging, and clinical and demographic information was gathered. Relationships between different types of amblyopia and OCT measurements were investigated. Results: Compared to the contralateral fellow eyes, the amblyopic eyes showed thicker fovea, and there were differences in foveal and macular thickness observed between the sexes. Individuals with anisometropic amblyopia exhibited a greater central macular thickness. While nasal optic nerve thickness was adversely correlated with age, inferior optic nerve thickness was considerably lower in amblyopia. Conclusions: This research indicates unique OCT traits in amblyopic eyes, which may have a role in amblyopia diagnosis and treatment. The prevention of long-term visual impairment depends heavily on early detection and care. More studies using larger cohorts and longitudinal designs are necessary to improve our knowledge of the pathogenesis of amblyopia and to provide the best possible clinical management approaches.
Open AccessDifferences Between Amblyopic and Fellow Eyes in Optical Coherence Tomography: A Cohort from Jordanian Population
Background and Objectives: Amblyopia is a condition where children undergo unilateral or bilateral vision loss due to a variety of disorders that impact the visual pathway. The assessment of retinal nerve fiber layer (RNFL) thickness in amblyopia has made optical coherence tomography (OCT) a useful technique for studying the pathophysiology of this condition. This study was conducted to assess OCT results for various forms of amblyopia, including macular thickness and peripapillary RNFL thickness. It is the first of its kind in Jordan. Materials and Methods: Sixty-one individuals, aged 14 to 67, who had been diagnosed with unilateral amblyopia participated in a prospective study. Both eyes underwent spectral-domain OCT imaging, and clinical and demographic information was gathered. Relationships between different types of amblyopia and OCT measurements were investigated. Results: Compared to the contralateral fellow eyes, the amblyopic eyes showed thicker fovea, and there were differences in foveal and macular thickness observed between the sexes. Individuals with anisometropic amblyopia exhibited a greater central macular thickness. While nasal optic nerve thickness was adversely correlated with age, inferior optic nerve thickness was considerably lower in amblyopia. Conclusions: This research indicates unique OCT traits in amblyopic eyes, which may have a role in amblyopia diagnosis and treatment. The prevention of long-term visual impairment depends heavily on early detection and care. More studies using larger cohorts and longitudinal designs are necessary to improve our knowledge of the pathogenesis of amblyopia and to provide the best possible clinical management approaches.
- Open Access
- 1 July 2024
- Published by International Virtual Ophthalmic Research Center in Medical hypothesis discovery and innovation in ophthalmology
- Vol. 13 (1) , 44-54
Keratoconus: imaging modalities and management
Background: Keratoconus (KCN) is characterized by gradual thinning and steepening of the cornea, which can lead to significant vision problems owing to high astigmatism, corneal scarring, or even corneal perforation. The detection of KCN in its early stages is crucial for effective treatment. In this review, we describe current advances in the diagnosis and treatment of KCN. Methods: This narrative review focuses on recent advancements in the diagnosis and treatment of KCN, especially evolving approaches and strategies. To ensure the inclusion of the most recent literature, relevant publications discussing advanced imaging techniques and treatment options for KCN were extensively gathered from the PubMed/MEDLINE and Google Scholar databases. The following index terms and keywords were used for the online search: keratoconus, diagnosis of keratoconus, advances in the diagnosis of keratoconus, topography or tomography, anterior segment optical coherence tomography, treatment of keratoconus, advances in the treatment of keratoconus, collagen crosslinking, intrastromal ring, keratoplasty, and new techniques in keratoconus. Results: Various screening methods such as corneal topography, tomography, anterior segment optical coherence tomography, and assessment of corneal biomechanics have been developed to identify KCN in its early stages. After diagnosis, KCN management focuses on preventing disease progression. Corneal collagen crosslinking is a minimally invasive treatment that can slow or stop the progression of the condition. Recent research has also explored the use of copper sulfate eye drops (IVMED-80) as a noninvasive treatment to prevent the progression of KCN. Current treatment options for visual improvement include scleral lenses, intracorneal ring segments, corneal allogeneic intrastromal ring segments, and deep anterior lamellar keratoplasty. Recently, novel alternative procedures, such as isolated Bowman layer transplantation, either as a corneal stromal inlay or onlay, have demonstrated encouraging outcomes. Artificial intelligence has gained acceptance for providing best practices for the diagnosis and management of KCN, and the science of its application is contentiously debated; however, it may not have been sufficiently developed. Conclusions: Early detection and advancements in screening methods using current imaging modalities have improved diagnosis of KCN. Improvement in the accuracy of current screening or diagnostic tests and comparison of their validities are achievable by well-designed, large-scale, prospective studies. The safety and effectiveness of emerging treatments for KCN are currently being investigated. There is an ongoing need for studies to track progress and evaluate clinicians’ knowledge and practices in treating patients with KCN. Artificial intelligence capabilities in management approach considering the currently available imaging modalities and treatment options would best benefit the patient.
- 1 July 2024
- Published by International Virtual Ophthalmic Research Center in Medical hypothesis discovery and innovation in ophthalmology
- Vol. 13 (1) , 44-54
Open AccessKeratoconus: imaging modalities and management
Background: Keratoconus (KCN) is characterized by gradual thinning and steepening of the cornea, which can lead to significant vision problems owing to high astigmatism, corneal scarring, or even corneal perforation. The detection of KCN in its early stages is crucial for effective treatment. In this review, we describe current advances in the diagnosis and treatment of KCN. Methods: This narrative review focuses on recent advancements in the diagnosis and treatment of KCN, especially evolving approaches and strategies. To ensure the inclusion of the most recent literature, relevant publications discussing advanced imaging techniques and treatment options for KCN were extensively gathered from the PubMed/MEDLINE and Google Scholar databases. The following index terms and keywords were used for the online search: keratoconus, diagnosis of keratoconus, advances in the diagnosis of keratoconus, topography or tomography, anterior segment optical coherence tomography, treatment of keratoconus, advances in the treatment of keratoconus, collagen crosslinking, intrastromal ring, keratoplasty, and new techniques in keratoconus. Results: Various screening methods such as corneal topography, tomography, anterior segment optical coherence tomography, and assessment of corneal biomechanics have been developed to identify KCN in its early stages. After diagnosis, KCN management focuses on preventing disease progression. Corneal collagen crosslinking is a minimally invasive treatment that can slow or stop the progression of the condition. Recent research has also explored the use of copper sulfate eye drops (IVMED-80) as a noninvasive treatment to prevent the progression of KCN. Current treatment options for visual improvement include scleral lenses, intracorneal ring segments, corneal allogeneic intrastromal ring segments, and deep anterior lamellar keratoplasty. Recently, novel alternative procedures, such as isolated Bowman layer transplantation, either as a corneal stromal inlay or onlay, have demonstrated encouraging outcomes. Artificial intelligence has gained acceptance for providing best practices for the diagnosis and management of KCN, and the science of its application is contentiously debated; however, it may not have been sufficiently developed. Conclusions: Early detection and advancements in screening methods using current imaging modalities have improved diagnosis of KCN. Improvement in the accuracy of current screening or diagnostic tests and comparison of their validities are achievable by well-designed, large-scale, prospective studies. The safety and effectiveness of emerging treatments for KCN are currently being investigated. There is an ongoing need for studies to track progress and evaluate clinicians’ knowledge and practices in treating patients with KCN. Artificial intelligence capabilities in management approach considering the currently available imaging modalities and treatment options would best benefit the patient.
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 16, 3043-3056
The Effect of Visual Impairment and Its Severity on Vision-Related and Health-Related Quality of Life in Jordan: A Comparative Cross-Sectional Study
Purpose: To assess the effect of visual impairment (VI), its severity, and ocular diseases on vision-related and health-related quality of life (QoL) in Jordan. Patients and Methods: A comparative, cross-sectional, hospital-based study was conducted among a group of 278 patients with VI aged ≥ 18 years, and age and sex-matched control group of 278 individuals with no VI. An interviewer administered the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Medical Outcomes Study 12-Item Short Form Health Survey (SF-12) to all participants. Results: All the mean VFQ-25 subscales scores, physical component scale (PCS) and the mental component scale (MCS) of the SF-12 were significantly lower in patients with VI compared to controls with no VI. The VFQ-25 subscales (except general health and ocular pain), PCS, and MCS scores significantly decreased with more severity of VI. In the adjusted multivariate analysis, lower level of education (p=0.013), male sex (p=0.016), and the presence of cerebrovascular disease (p=0.019) were significantly associated with lower VFQ-25 composite scores in visually impaired patients compared to controls. Ocular disease duration of > 5 years and progressive VI were significantly associated with lower VFQ-25 composite scores (p= 0.026 and p< 0.001) respectively, in patients with VI. Glaucoma had a significantly larger reduction in mean scores of all the VFQ-25 subscales, and the PCS of the SF-12 compared to all other ocular diseases. Conclusion: Both VI and increasing severity of impairment were associated with reduced vision-related and health-related quality of life in adult Jordanians. Glaucoma patients and less educated people were particularly affected. Routine assessment of QoL in visually impaired patients and improving referral protocols to vision rehabilitation services is recommended to improve the QoL in those patients.
- 1 October 2023
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 16, 3043-3056
Open AccessThe Effect of Visual Impairment and Its Severity on Vision-Related and Health-Related Quality of Life in Jordan: A Comparative Cross-Sectional Study
Purpose: To assess the effect of visual impairment (VI), its severity, and ocular diseases on vision-related and health-related quality of life (QoL) in Jordan. Patients and Methods: A comparative, cross-sectional, hospital-based study was conducted among a group of 278 patients with VI aged ≥ 18 years, and age and sex-matched control group of 278 individuals with no VI. An interviewer administered the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Medical Outcomes Study 12-Item Short Form Health Survey (SF-12) to all participants. Results: All the mean VFQ-25 subscales scores, physical component scale (PCS) and the mental component scale (MCS) of the SF-12 were significantly lower in patients with VI compared to controls with no VI. The VFQ-25 subscales (except general health and ocular pain), PCS, and MCS scores significantly decreased with more severity of VI. In the adjusted multivariate analysis, lower level of education (p=0.013), male sex (p=0.016), and the presence of cerebrovascular disease (p=0.019) were significantly associated with lower VFQ-25 composite scores in visually impaired patients compared to controls. Ocular disease duration of > 5 years and progressive VI were significantly associated with lower VFQ-25 composite scores (p= 0.026 and p< 0.001) respectively, in patients with VI. Glaucoma had a significantly larger reduction in mean scores of all the VFQ-25 subscales, and the PCS of the SF-12 compared to all other ocular diseases. Conclusion: Both VI and increasing severity of impairment were associated with reduced vision-related and health-related quality of life in adult Jordanians. Glaucoma patients and less educated people were particularly affected. Routine assessment of QoL in visually impaired patients and improving referral protocols to vision rehabilitation services is recommended to improve the QoL in those patients.
- Open Access
- 1 November 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 3811-3819
Outcomes of Iris-Claw IOL Implantation in Patients with Marfan’s Syndrome in Jordan
Objective: The management of ocular complications of Marfan’s syndrome, especially ectopia lentis, is challenging. In this study, we present the effectiveness and the safety of iris-claw intraocular lens (IOL) implantation along with lensectomy for those patients. Also, we compare the practice of implanting these IOLs either in the anterior chamber of retropupillary. Methods: Retrospectively, we included all patients with Marfan’s syndrome who underwent lensectomy with iris-claw IOL implantation as a result of ectopia lentis. The patients were categorized into two groups: anterior chamber iris claw IOL and retropupillary iris-claw IOL. The clinical and demographic data, the visual outcome and postoperative complications were compared. Results: Eighteen eyes of 10 patients were included in the study. The mean age of the patients was 19.1 years. Six patients were males. The iris-claw IOL was implanted anteriorly in 13 eyes. The visual outcome was comparable between both groups and most patients achieved improvement in the visual acuity. In addition, the postoperative complications developed similarly in both groups. However, all cases of IOL disenclavation (6 cases) developed in the anterior group. It is revealed that the age of the patient was the most significant factor affecting the occurrence of IOL disenclavation. Conclusion: Iris-claw IOL (either anteriorly or retropupillary) is an effective and relatively safe method in treating ectopia lentis in patients with Marfan’s syndrome. In younger patients, anterior iris-claw IOL is safer than retropupillary iris-claw IOL as the risk of disenclavation is higher in younger patients.
- 1 November 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 3811-3819
Open AccessOutcomes of Iris-Claw IOL Implantation in Patients with Marfan’s Syndrome in Jordan
Objective: The management of ocular complications of Marfan’s syndrome, especially ectopia lentis, is challenging. In this study, we present the effectiveness and the safety of iris-claw intraocular lens (IOL) implantation along with lensectomy for those patients. Also, we compare the practice of implanting these IOLs either in the anterior chamber of retropupillary. Methods: Retrospectively, we included all patients with Marfan’s syndrome who underwent lensectomy with iris-claw IOL implantation as a result of ectopia lentis. The patients were categorized into two groups: anterior chamber iris claw IOL and retropupillary iris-claw IOL. The clinical and demographic data, the visual outcome and postoperative complications were compared. Results: Eighteen eyes of 10 patients were included in the study. The mean age of the patients was 19.1 years. Six patients were males. The iris-claw IOL was implanted anteriorly in 13 eyes. The visual outcome was comparable between both groups and most patients achieved improvement in the visual acuity. In addition, the postoperative complications developed similarly in both groups. However, all cases of IOL disenclavation (6 cases) developed in the anterior group. It is revealed that the age of the patient was the most significant factor affecting the occurrence of IOL disenclavation. Conclusion: Iris-claw IOL (either anteriorly or retropupillary) is an effective and relatively safe method in treating ectopia lentis in patients with Marfan’s syndrome. In younger patients, anterior iris-claw IOL is safer than retropupillary iris-claw IOL as the risk of disenclavation is higher in younger patients.
- Open Access
- 1 October 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 15, 4259-4267
Preferred Surgical and Anesthesia Techniques for Cataract Surgery in Jordan
Purpose: To study the current practices in Jordan regarding cataract surgical procedures and anesthesia trends for cataract surgery. Methods: A cross-sectional survey of members of the Jordanian Ophthalmology Society was conducted in October 2020. The questionnaire included questions about participants’ demographics, the preferred surgical techniques for cataracts, the preferred anesthesia technique for cataract surgery, the factors which affect the choice of anesthesia technique, the use of sedation, who gives the anesthesia, if there is an anesthesia-trained person who observes the patient during cataract surgery, and the changing trends towards anesthesia between the surgeons. Results: More than half of the respondents (59.1%) had been in practice for more than 5 years. The preferred method for routine cataract was phacoemulsification for most participants (98.4%). For mature cataract, phacoemulsification was the preferred method for 61.4% of participants. More than half (55.1%) used topical with intracameral anesthesia for phacoemulsification. Two thirds of the participants (66.3%) performed retrobulbar anesthesia for extracapsular cataract surgery. In the majority of cases (86.6%), the respondent themself is the one who administers the anesthesia. No sedation was used before surgery in 62.6% of cases. Two thirds of the respondents (70.1%) reported that they had an anesthesia-trained person monitoring the patient during surgery. Patient cooperation was the most important factor (70.9%) affecting the surgeon’s choice of anesthesia technique followed by surgeon skill and experience (57.5%). Conclusion: Presently, phacoemulsification is the preferred surgical technique for cataract in Jordan. Topical with intracameral anesthesia is the most common anesthesia for phacoemulsification while retrobulbar anesthesia is the most common for extracapsular cataract extraction.
- 1 October 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 15, 4259-4267
Open AccessPreferred Surgical and Anesthesia Techniques for Cataract Surgery in Jordan
Purpose: To study the current practices in Jordan regarding cataract surgical procedures and anesthesia trends for cataract surgery. Methods: A cross-sectional survey of members of the Jordanian Ophthalmology Society was conducted in October 2020. The questionnaire included questions about participants’ demographics, the preferred surgical techniques for cataracts, the preferred anesthesia technique for cataract surgery, the factors which affect the choice of anesthesia technique, the use of sedation, who gives the anesthesia, if there is an anesthesia-trained person who observes the patient during cataract surgery, and the changing trends towards anesthesia between the surgeons. Results: More than half of the respondents (59.1%) had been in practice for more than 5 years. The preferred method for routine cataract was phacoemulsification for most participants (98.4%). For mature cataract, phacoemulsification was the preferred method for 61.4% of participants. More than half (55.1%) used topical with intracameral anesthesia for phacoemulsification. Two thirds of the participants (66.3%) performed retrobulbar anesthesia for extracapsular cataract surgery. In the majority of cases (86.6%), the respondent themself is the one who administers the anesthesia. No sedation was used before surgery in 62.6% of cases. Two thirds of the respondents (70.1%) reported that they had an anesthesia-trained person monitoring the patient during surgery. Patient cooperation was the most important factor (70.9%) affecting the surgeon’s choice of anesthesia technique followed by surgeon skill and experience (57.5%). Conclusion: Presently, phacoemulsification is the preferred surgical technique for cataract in Jordan. Topical with intracameral anesthesia is the most common anesthesia for phacoemulsification while retrobulbar anesthesia is the most common for extracapsular cataract extraction.